Stanford's Inflammatory Bowel Disease (IBD) Program is nationally
recognized for specialized care of patients with Crohn's disease,
ulcerative colitis, microscopic colitis and other related diseases. We
provide a thorough evaluation and comprehensive management for adults
with Inflammatory Bowel Disease and Ulcerative Colitis. As IBD
treatment continues to evolve, we are at the forefront of research,
including participation in clinical trials for the latest medical
breakthroughs in the field of Inflammatory Bowel Disease.
BENEFITS TO YOU
Our IBD Program is nationally recognized. Our research efforts continue to improve therapies and treatment protocols for inflammatory bowel disease.
Our multi-disciplinary treatment approach ensures the development of a comprehensive care plan that maximizes independence and improves quality of life.
Multidisciplinary approach to patient care with team of
specialists including gastroenterologists, surgeons, radiologists,
pathologists, immunologists, nutritionists, ostomy nurses.
Broad-based knowledge in every area of IBD and Ulcerative
Use and development of new diagnostic
tools for diagnosing and assessing IBD and Ulcerative Colitis.
Leading therapy directed at improving patient quality of life
and incorporating patient's input regarding treatment
Collaborative novel research with other
subspecialties including colorectal surgeons, pediatric
Endoscopic procedures for diagnostic purposes: Please see
procedures and preparation for more information.